ChartMill · Aug 19, 2026
What's going on in today's after hours session
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
VR
NASDAQ · VRAX
Virax Biolabs Group Limited
Healthcare · Biotechnology
$2.53
Up+$0.04 (+1.61%)
Updated Sep 18, 2026, 7:06 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.92M
- P/E ratio
- -0.37
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $13.19
- Volume
- 17.96K
- Avg. volume
- 5.08M
Price performance
VRAX price history
1M range · 20 trading sessions · Daily adjusted prices
VRAX closed at $2.53 after 20 trading sessions, down 26.67% for the selected period.
- Last close
- $2.53
- Period change
- -26.67%
- Period low
- $2.49
- Period high
- $3.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $2.53 | $2.60 | $2.50 | $2.53 | 17.96K |
| Sep 16, 2026 | $2.59 | $2.59 | $2.45 | $2.49 | 23.76K |
| Sep 15, 2026 | $2.66 | $2.775 | $2.58 | $2.59 | 24.4K |
| Sep 14, 2026 | $2.59 | $2.75 | $2.58 | $2.61 | 31.44K |
| Sep 11, 2026 | $2.77 | $2.84 | $2.60 | $2.67 | 42.96K |
| Sep 10, 2026 | $2.73 | $2.92 | $2.70 | $2.85 | 72.4K |
| Sep 9, 2026 | $2.66 | $2.76 | $2.63 | $2.73 | 38.54K |
| Sep 8, 2026 | $2.60 | $2.66 | $2.56 | $2.63 | 29.08K |
| Sep 4, 2026 | $2.54 | $2.635 | $2.54 | $2.625 | 21.86K |
| Sep 3, 2026 | $2.625 | $2.69 | $2.52 | $2.56 | 40.22K |
| Sep 2, 2026 | $2.56 | $2.61 | $2.54 | $2.545 | 25.19K |
| Sep 1, 2026 | $2.82 | $2.835 | $2.56 | $2.60 | 86.17K |
| Aug 31, 2026 | $2.92 | $2.92 | $2.77 | $2.82 | 16.94K |
| Aug 28, 2026 | $2.89 | $2.945 | $2.75 | $2.82 | 37.11K |
| Aug 27, 2026 | $2.80 | $2.95 | $2.72 | $2.94 | 48.92K |
| Aug 26, 2026 | $2.87 | $2.94 | $2.73 | $2.77 | 92.57K |
| Aug 25, 2026 | $3.00 | $3.00 | $2.90 | $2.91 | 36.23K |
| Aug 24, 2026 | $3.14 | $3.19 | $2.90 | $3.00 | 81.03K |
| Aug 21, 2026 | $3.51 | $3.51 | $3.14 | $3.19 | 120.59K |
| Aug 20, 2026 | $3.20 | $3.64 | $3.10 | $3.45 | 499.04K |
Latest VRAX news
The latest Smart Investors Daily articles mentioning VRAX.
Stock researchCompany · Overview
VRAX research
Overview
Company profile and research snapshot.
Company profile
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jan 9, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 31, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 19, 2026
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers BioVie (NASDAQ:BIVI) stock increased by 15.7% to $1.55 during Wednesday's after-market session. The market value of their outstanding shares is at $7.2 million. The company's, Q4 earnings came out 4
Benzinga · Aug 19, 2026
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.6 million. As per the news, the Q2 earnings report came
Benzinga · Jul 24, 2026
Virax Biolabs Files Prospectus For Offering 1.682M Ordinary Shares
https://www.sec.gov/Archives/edgar/data/1885827/000119312526316130/vrax-20260724.htm
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
